Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling

1 Children's Exercise and Nutrition Centre and 2 Departments of Pediatrics and Medicine, McMaster University, Hamilton, Ontario, Canada Submitted 10 February 2005 ; accepted in final form 4 May 2005 This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC)...

Full description

Saved in:
Bibliographic Details
Published inJournal of applied physiology (1985) Vol. 99; no. 3; pp. 979 - 985
Main Authors Timmons, Brian W, Hamadeh, Mazen J, Devries, Michaela C, Tarnopolsky, Mark A
Format Journal Article
LanguageEnglish
Published Bethesda, MD Am Physiological Soc 01.09.2005
American Physiological Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 1 Children's Exercise and Nutrition Centre and 2 Departments of Pediatrics and Medicine, McMaster University, Hamilton, Ontario, Canada Submitted 10 February 2005 ; accepted in final form 4 May 2005 This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC) use on immunological changes in response to endurance exercise. Twelve women and 11 men similar in age, aerobic power, and activity level cycled for 90 min at 65% maximal aerobic power. Women were OC users ( n = 6) or nonusers (NOC) and cycled during the follicular (Fol) and the luteal (Lut) phases. Venous blood was collected before and after exercise to determine leukocyte counts, IL-6 concentrations, and cortisol. Higher resting levels of neutrophils ( 1.5-fold) and cortisol ( 2.5-fold) were found in OC vs. NOC and men. Exercise-induced immune cell count and IL-6 changes were similar between men and NOC, except for an 38% greater lymphocyte response in NOC vs. men ( P = 0.07). Neutrophil, monocyte, and lymphocyte responses to exercise during Lut in OC were greater than during Fol and also greater than the responses in men ( P 0.003). Changes in immune cell counts were consistently greater during Lut in OC vs. NOC, regardless of MP, but only neutrophil responses reached statistical significance ( P = 0.01). The exercise-induced change in IL-6 was 80% greater in NOC vs. OC during Fol ( P = 0.06), but it was similar between these groups during Lut. Cortisol changes with exercise were not different between groups or MP. These results highlight the necessity to control for gender, and in particular OC use, when designing studies evaluating exercise and immunology. interleukin-6; lymphocytes Address for reprint requests and other correspondence: M. A. Tarnopolsky, Rm. 4U4, Depts. of Pediatrics and Medicine, McMaster Univ. Medical Center, 1200 Main St., West Hamilton, Ontario, Canada L8N 3Z5 (e-mail: tarnopol{at}mcmaster.ca )
AbstractList 1 Children's Exercise and Nutrition Centre and 2 Departments of Pediatrics and Medicine, McMaster University, Hamilton, Ontario, Canada Submitted 10 February 2005 ; accepted in final form 4 May 2005 This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC) use on immunological changes in response to endurance exercise. Twelve women and 11 men similar in age, aerobic power, and activity level cycled for 90 min at 65% maximal aerobic power. Women were OC users ( n = 6) or nonusers (NOC) and cycled during the follicular (Fol) and the luteal (Lut) phases. Venous blood was collected before and after exercise to determine leukocyte counts, IL-6 concentrations, and cortisol. Higher resting levels of neutrophils ( 1.5-fold) and cortisol ( 2.5-fold) were found in OC vs. NOC and men. Exercise-induced immune cell count and IL-6 changes were similar between men and NOC, except for an 38% greater lymphocyte response in NOC vs. men ( P = 0.07). Neutrophil, monocyte, and lymphocyte responses to exercise during Lut in OC were greater than during Fol and also greater than the responses in men ( P 0.003). Changes in immune cell counts were consistently greater during Lut in OC vs. NOC, regardless of MP, but only neutrophil responses reached statistical significance ( P = 0.01). The exercise-induced change in IL-6 was 80% greater in NOC vs. OC during Fol ( P = 0.06), but it was similar between these groups during Lut. Cortisol changes with exercise were not different between groups or MP. These results highlight the necessity to control for gender, and in particular OC use, when designing studies evaluating exercise and immunology. interleukin-6; lymphocytes Address for reprint requests and other correspondence: M. A. Tarnopolsky, Rm. 4U4, Depts. of Pediatrics and Medicine, McMaster Univ. Medical Center, 1200 Main St., West Hamilton, Ontario, Canada L8N 3Z5 (e-mail: tarnopol{at}mcmaster.ca )
This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC) use on immunological changes in response to endurance exercise. Twelve women and 11 men similar in age, aerobic power, and activity level cycled for 90 min at 65% maximal aerobic power. Women were OC users ( n = 6) or nonusers (NOC) and cycled during the follicular (Fol) and the luteal (Lut) phases. Venous blood was collected before and after exercise to determine leukocyte counts, IL-6 concentrations, and cortisol. Higher resting levels of neutrophils (∼1.5-fold) and cortisol (∼2.5-fold) were found in OC vs. NOC and men. Exercise-induced immune cell count and IL-6 changes were similar between men and NOC, except for an ∼38% greater lymphocyte response in NOC vs. men ( P = 0.07). Neutrophil, monocyte, and lymphocyte responses to exercise during Lut in OC were greater than during Fol and also greater than the responses in men ( P ≤ 0.003). Changes in immune cell counts were consistently greater during Lut in OC vs. NOC, regardless of MP, but only neutrophil responses reached statistical significance ( P = 0.01). The exercise-induced change in IL-6 was ∼80% greater in NOC vs. OC during Fol ( P = 0.06), but it was similar between these groups during Lut. Cortisol changes with exercise were not different between groups or MP. These results highlight the necessity to control for gender, and in particular OC use, when designing studies evaluating exercise and immunology.
This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC) use on immunological changes in response to endurance exercise. Twelve women and 11 men similar in age, aerobic power, and activity level cycled for 90 min at 65% maximal aerobic power. Women were OC users (n = 6) or nonusers (NOC) and cycled during the follicular (Fol) and the luteal (Lut) phases. Venous blood was collected before and after exercise to determine leukocyte counts, IL-6 concentrations, and cortisol. Higher resting levels of neutrophils (approximately 1.5-fold) and cortisol (approximately 2.5-fold) were found in OC vs. NOC and men. Exercise-induced immune cell count and IL-6 changes were similar between men and NOC, except for an approximately 38% greater lymphocyte response in NOC vs. men (P = 0.07). Neutrophil, monocyte, and lymphocyte responses to exercise during Lut in OC were greater than during Fol and also greater than the responses in men (P < or = 0.003). Changes in immune cell counts were consistently greater during Lut in OC vs. NOC, regardless of MP, but only neutrophil responses reached statistical significance (P = 0.01). The exercise-induced change in IL-6 was approximately 80% greater in NOC vs. OC during Fol (P = 0.06), but it was similar between these groups during Lut. Cortisol changes with exercise were not different between groups or MP. These results highlight the necessity to control for gender, and in particular OC use, when designing studies evaluating exercise and immunology.
This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC) use on immunological changes in response to endurance exercise. Twelve women and 11 men similar in age, aerobic power, and activity level cycled for 90 min at 65% maximal aerobic power. Women were OC users (n = 6) or nonusers (NOC) and cycled during the follicular (Fol) and the luteal (Lut) phases. Venous blood was collected before and after exercise to determine leukocyte counts, IL-6 concentrations, and cortisol. Higher resting levels of neutrophils (approximately 1.5-fold) and cortisol (approximately 2.5-fold) were found in OC vs. NOC and men. Exercise-induced immune cell count and IL-6 changes were similar between men and NOC, except for an approximately 38% greater lymphocyte response in NOC vs. men (P = 0.07). Neutrophil, monocyte, and lymphocyte responses to exercise during Lut in OC were greater than during Fol and also greater than the responses in men (P &lt; or = 0.003). Changes in immune cell counts were consistently greater during Lut in OC vs. NOC, regardless of MP, but only neutrophil responses reached statistical significance (P = 0.01). The exercise-induced change in IL-6 was approximately 80% greater in NOC vs. OC during Fol (P = 0.06), but it was similar between these groups during Lut. Cortisol changes with exercise were not different between groups or MP. These results highlight the necessity to control for gender, and in particular OC use, when designing studies evaluating exercise and immunology.
This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC) use on immunological changes in response to endurance exercise. Twelve women and 11 men similar in age, aerobic power, and activity level cycled for 90 min at 65% maximal aerobic power. Women were OC users (n = 6) or nonusers (NOC) and cycled during the follicular (Fol) and the luteal (Lut) phases. Venous blood was collected before and after exercise to determine leukocyte counts, IL-6 concentrations, and cortisol. Higher resting levels of neutrophils ( similar to 1.5-fold) and cortisol ( similar to 2.5-fold) were found in OC vs. NOC and men. Exercise-induced immune cell count and IL-6 changes were similar between men and NOC, except for an similar to 38% greater lymphocyte response in NOC vs. men (P = 0.07). Neutrophil, monocyte, and lymphocyte responses to exercise during Lut in OC were greater than during Fol and also greater than the responses in men (P less than or equal to 0.003). Changes in immune cell counts were consistently greater during Lut in OC vs. NOC, regardless of MP, but only neutrophil responses reached statistical significance (P = 0.01). The exercise-induced change in IL-6 was similar to 80% greater in NOC vs. OC during Fol (P = 0.06), but it was similar between these groups during Lut. Cortisol changes with exercise were not different between groups or MP. These results highlight the necessity to control for gender, and in particular OC use, when designing studies evaluating exercise and immunology.
This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC) use on immunological changes in response to endurance exercise. Twelve women and 11 men similar in age, aerobic power, and activity level cycled for 90 min at 65% maximal aerobic power. Women were OC users (n = 6) or nonusers (NOC) and cycled during the follicular (Fol) and the luteal (Lut) phases. Venous blood was collected before and after exercise to determine leukocyte counts, IL-6 concentrations, and cortisol. Higher resting levels of neutrophils (about 1.5-fold) and cortisol (about 2.5-fold) were found in OC vs. NOC and men. Exercise-induced immune cell count and IL-6 changes were similar between men and NOC, except for an about 38% greater lymphocyte response in NOC vs. men (P = 0.07). Neutrophil, monocyte, and lymphocyte responses to exercise during Lut in OC were greater than during Fol and also greater than the responses in men (P less than or equal to 0.003). Changes in immune cell counts were consistently greater during Lut in OC vs. NOC, regardless of MP, but only neutrophil responses reached statistical significance (P = 0.01). The exercise-induced change in IL-6 was about 80% greater in NOC vs. OC during Fol (P = 0.06), but it was similar between these groups during Lut. Cortisol changes with exercise were not different between groups or MP. These results highlight the necessity to control for gender, and in particular OC use, when designing studies evaluating exercise and immunology. [PUBLICATION ABSTRACT]
Author Hamadeh, Mazen J
Devries, Michaela C
Timmons, Brian W
Tarnopolsky, Mark A
Author_xml – sequence: 1
  fullname: Timmons, Brian W
– sequence: 2
  fullname: Hamadeh, Mazen J
– sequence: 3
  fullname: Devries, Michaela C
– sequence: 4
  fullname: Tarnopolsky, Mark A
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17062735$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15879167$$D View this record in MEDLINE/PubMed
BookMark eNqFkVGP1CAQx4k54-2dfgUlJurLdYVSyvJoLp5ecokv5zNh6bRlQ6FCq66fXurWnDEx8kKY-f1nmPlfoDMfPCD0gpItpbx8e9Dj6Mb-mGxwW0KooNuSEP4IbXK2LGhN6Bna7AQnheA7cY4uUjpkrqo4fYLOaY5JWosN-nHrWzeDN4BDizvwDcQrPIBPU5y1w2OvE1xh7RscYn6b4KeoDYyT_Qp4TlnmsR2G2QcXOmsWpNe-g4StxxHSGHyGpoDHmImcaLA5Gmd99xQ9brVL8Gy9L9Hnm_f31x-Lu08fbq_f3RWGSzIVZd1QyUvBqK4aqtuaM8jjGVJVFeGUVjUhZSOZLluhNZiaMbkntdjLBloiDLtEr0918w--zJAmNdhkwDntIcxJ1btqR1m5-y9IRUVLzuoMvvwLPIQ5-jyEKvMhFWciQ-IEmRhSitCqMdpBx6OiRC0mqj9NVL9MVIuJWfl8LT_vB2gedKtrGXi1AjrljbdRe2PTAydInfe1FHpz4nrb9d9sBLV2C91x6a6kVExJITPJ_k3ezM7dw_dpkfxWqLFp2U8dacxQ
CODEN JAPHEV
CitedBy_id crossref_primary_10_1249_MSS_0b013e31817d1cce
crossref_primary_10_1371_journal_pone_0298429
crossref_primary_10_3390_life11070622
crossref_primary_10_1139_apnm_2014_0468
crossref_primary_10_1007_s00421_010_1789_8
crossref_primary_10_1249_01_mss_0000183479_90501_a0
crossref_primary_10_1249_mss_0b013e31815aedda
crossref_primary_10_3390_sports4040051
crossref_primary_10_1152_ajpheart_00532_2012
crossref_primary_10_3389_fphys_2022_998925
crossref_primary_10_1162_jocn_a_01687
crossref_primary_10_1007_s00421_013_2592_0
crossref_primary_10_2165_11590430_000000000_00000
crossref_primary_10_1089_ars_2007_1596
crossref_primary_10_3389_fphys_2019_01602
crossref_primary_10_1007_s00421_010_1730_1
crossref_primary_10_1152_physrev_90100_2007
crossref_primary_10_1080_16549716_2020_1777713
crossref_primary_10_3389_fphys_2020_00497
crossref_primary_10_1080_09291010802067213
crossref_primary_10_1080_02640414_2018_1478612
crossref_primary_10_1152_japplphysiol_01051_2020
crossref_primary_10_1097_01_CCM_0000266793_09378_22
crossref_primary_10_1007_s00421_012_2314_z
crossref_primary_10_1139_apnm_2015_0488
crossref_primary_10_1186_1550_2783_11_39
crossref_primary_10_1080_02640414_2014_990488
crossref_primary_10_3390_antiox10111846
crossref_primary_10_3389_falgy_2022_875295
crossref_primary_10_3389_fphys_2022_833580
crossref_primary_10_3390_sports11110229
crossref_primary_10_3390_ijerph17051618
crossref_primary_10_1007_s00421_008_0866_8
crossref_primary_10_1007_s00421_023_05275_4
crossref_primary_10_1016_j_cyto_2022_155872
crossref_primary_10_2165_11598900_000000000_00000
crossref_primary_10_7570_jomes_2018_27_4_264
crossref_primary_10_1177_1559827606294851
crossref_primary_10_1186_s12974_016_0758_5
crossref_primary_10_3390_ijms21113816
crossref_primary_10_1007_s00421_019_04254_y
crossref_primary_10_1152_japplphysiol_01125_2005
crossref_primary_10_14814_phy2_15010
crossref_primary_10_1016_j_smhs_2021_08_004
crossref_primary_10_3390_nu14204346
crossref_primary_10_1016_j_yfrne_2022_100998
crossref_primary_10_1111_apha_14013
crossref_primary_10_1152_ajpregu_00605_2005
crossref_primary_10_1016_j_idnow_2024_104893
crossref_primary_10_1016_j_msard_2019_03_025
crossref_primary_10_1519_JSC_0b013e3181df7fd2
crossref_primary_10_1152_ajpheart_00123_2015
crossref_primary_10_3390_metabo11060334
crossref_primary_10_1007_s00421_021_04819_w
crossref_primary_10_1016_j_ejphar_2020_173762
crossref_primary_10_2165_11536920_000000000_00000
crossref_primary_10_1016_j_jesf_2014_10_002
crossref_primary_10_1016_j_vaccine_2015_03_098
crossref_primary_10_1152_ajpregu_00014_2021
crossref_primary_10_3390_ijerph19159201
crossref_primary_10_2466_05_06_PMS_113_6_764_772
crossref_primary_10_1016_j_bbi_2006_04_158
crossref_primary_10_1080_02701367_2011_10599806
crossref_primary_10_1055_a_2197_0882
crossref_primary_10_1249_MSS_0000000000001029
Cites_doi 10.1007/PL00013796
10.1152/jappl.2001.91.1.109
10.1152/jappl.1960.15.1.31
10.1007/BF00377445
10.1097/00005768-199808000-00003
10.1542/peds.47.1.120
10.1073/pnas.89.21.9991
10.1016/S0531-5565(00)00195-9
10.1097/00003677-200107000-00004
10.1097/00005768-199703000-00008
10.1097/00075197-200111000-00012
10.1016/S0015-0282(01)01971-9
10.1139/y01-011
10.1055/s-2007-1021028
10.1210/jcem.85.1.6328
10.1139/h00-024
10.1038/nm1295-1279
10.1016/0024-3205(84)90411-9
10.1152/ajpregu.2000.279.4.R1251
10.1111/j.1365-2125.1994.tb04308.x
10.1097/00005768-200105001-00865
10.1006/cyto.1999.0570
10.1152/jappl.1998.85.5.1823
10.1152/ajpcell.00509.2002
10.1111/j.1600-0897.1998.tb00398.x
10.1113/jphysiol.1932.sp002879
10.1111/j.1469-7793.2000.00237.x
10.1055/s-2007-1002181
10.1152/jappl.1974.37.2.247
10.1006/gyno.2001.6153
10.1016/S0009-9236(96)90172-1
10.1016/0009-8981(90)90175-R
10.1111/j.1469-7793.2001.00633.x
10.1016/S0015-0282(00)01553-3
10.1006/cyto.1996.0178
10.1152/ajpendo.00134.2003
10.2165/00007256-198806060-00002
10.1080/07315724.2004.10719376
10.1080/026404102753576116
10.1530/eje.0.1430031
10.1152/physrev.2000.80.3.1055
10.1152/jappl.2000.89.6.2325
10.1055/s-2007-972899
10.1016/0024-3205(93)90002-K
10.1249/00005768-199204000-00007
10.1006/brbi.1999.0570
10.1016/S0015-0282(99)00325-8
10.1111/j.1749-6632.1998.tb08334.x
10.1016/S0002-9378(99)70332-7
10.1007/BF00377443
10.1152/jappl.1991.70.5.1917
10.1016/S8756-3282(99)00243-4
10.4049/jimmunol.153.1.300
10.1139/h00-022
10.1210/jc.86.6.2403
ContentType Journal Article
Copyright 2005 INIST-CNRS
Copyright American Physiological Society Sep 2005
Copyright_xml – notice: 2005 INIST-CNRS
– notice: Copyright American Physiological Society Sep 2005
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7QR
7TK
7TS
7U7
8FD
C1K
FR3
P64
7X8
DOI 10.1152/japplphysiol.00171.2005
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Physical Education Index
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Technology Research Database
Toxicology Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE
MEDLINE - Academic
Physical Education Index
Technology Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1601
EndPage 985
ExternalDocumentID 886833711
10_1152_japplphysiol_00171_2005
15879167
17062735
jap_99_3_979
Genre Controlled Clinical Trial
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
Feature
GroupedDBID -
02
2WC
39C
3O-
4.4
53G
55
5VS
85S
AALRV
ABFLS
ABOCM
ABUFD
ACGFS
ACIWK
ACPRK
ADBBV
ADBIT
AEILP
AENEX
AEULQ
AFDAS
AFRAH
AGCDD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GJ
GX1
H13
H~9
KQ8
L7B
MYA
NEJ
O0-
OHT
OK1
P-O
P2P
PQEST
PQQKQ
RAP
RHF
RHI
RPL
SJN
UHB
UKR
UPT
WH7
WOQ
X
X7M
YCJ
---
-~X
.55
.GJ
08R
18M
1CY
29J
476
8M5
AAFWJ
AAUGY
ABCQX
ABDNZ
ABKWE
ACBEA
ACGFO
ACKIV
ACYGS
ADFNX
AETEA
AFMIJ
AFOSN
AGNAY
AI.
AIDAL
AJUXI
BKKCC
BTFSW
C2-
EMOBN
F3I
IQODW
ITBOX
J5H
MVM
P6G
RPRKH
TR2
VH1
W8F
XOL
XSW
YBH
YQJ
YQT
YWH
ZXP
~02
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7QR
7TK
7TS
7U7
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c590t-26d1952731a4d1af653e601c0444051146002d93a2f7aaec6339b067b9def07c3
ISSN 8750-7587
IngestDate Fri Aug 16 23:47:52 EDT 2024
Fri Aug 16 10:40:52 EDT 2024
Fri Sep 13 04:09:26 EDT 2024
Thu Sep 12 16:53:50 EDT 2024
Thu May 23 23:10:36 EDT 2024
Sun Oct 29 17:09:58 EDT 2023
Mon May 06 11:51:24 EDT 2019
Tue Jan 05 17:53:22 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Physical exercise
Human
lymphocytes
Cyclism
Immunomodulation
Cytokine
Sex
Oral administration
interleukin-6
Interleukin 6
Sport
Female
Contraceptive
Lymphocyte
Prolonged
Immune system
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c590t-26d1952731a4d1af653e601c0444051146002d93a2f7aaec6339b067b9def07c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink http://jap.physiology.org/content/jap/99/3/979.full.pdf
PMID 15879167
PQID 222204537
PQPubID 40905
PageCount 7
ParticipantIDs proquest_miscellaneous_68481328
pascalfrancis_primary_17062735
pubmed_primary_15879167
highwire_physiology_jap_99_3_979
proquest_miscellaneous_17412536
proquest_journals_222204537
crossref_primary_10_1152_japplphysiol_00171_2005
PublicationCentury 2000
PublicationDate 2005-09-01
PublicationDateYYYYMMDD 2005-09-01
PublicationDate_xml – month: 09
  year: 2005
  text: 2005-09-01
  day: 01
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
– name: Bethesda
PublicationTitle Journal of applied physiology (1985)
PublicationTitleAlternate J Appl Physiol (1985)
PublicationYear 2005
Publisher Am Physiological Soc
American Physiological Society
Publisher_xml – name: Am Physiological Soc
– name: American Physiological Society
References R21
R20
R23
R22
R25
R24
R27
R26
R29
R28
R1
R2
R3
R4
R5
R6
R7
R8
R9
R30
R32
R31
R34
R33
R36
R35
R38
R37
R39
R41
R40
R43
R42
R45
R44
R47
R46
R49
R48
R50
R52
R51
R10
R54
R53
R12
R56
R11
R55
R14
R58
R13
R57
R16
R15
R59
R18
R17
R19
References_xml – ident: R30
  doi: 10.1007/PL00013796
– ident: R42
  doi: 10.1152/jappl.2001.91.1.109
– ident: R14
  doi: 10.1152/jappl.1960.15.1.31
– ident: R39
  doi: 10.1007/BF00377445
– ident: R56
  doi: 10.1097/00005768-199808000-00003
– ident: R35
  doi: 10.1542/peds.47.1.120
– ident: R12
  doi: 10.1073/pnas.89.21.9991
– ident: R45
  doi: 10.1016/S0531-5565(00)00195-9
– ident: R22
  doi: 10.1097/00003677-200107000-00004
– ident: R57
  doi: 10.1097/00005768-199703000-00008
– ident: R25
  doi: 10.1097/00075197-200111000-00012
– ident: R8
  doi: 10.1016/S0015-0282(01)01971-9
– ident: R54
  doi: 10.1139/y01-011
– ident: R55
  doi: 10.1055/s-2007-1021028
– ident: R13
  doi: 10.1210/jcem.85.1.6328
– ident: R52
  doi: 10.1139/h00-024
– ident: R1
  doi: 10.1038/nm1295-1279
– ident: R21
  doi: 10.1016/0024-3205(84)90411-9
– ident: R40
  doi: 10.1152/ajpregu.2000.279.4.R1251
– ident: R58
  doi: 10.1111/j.1365-2125.1994.tb04308.x
– ident: R6
  doi: 10.1097/00005768-200105001-00865
– ident: R15
– ident: R47
  doi: 10.1006/cyto.1999.0570
– ident: R24
  doi: 10.1152/jappl.1998.85.5.1823
– ident: R49
  doi: 10.1152/ajpcell.00509.2002
– ident: R11
  doi: 10.1111/j.1600-0897.1998.tb00398.x
– ident: R31
  doi: 10.1113/jphysiol.1932.sp002879
– ident: R50
  doi: 10.1111/j.1469-7793.2000.00237.x
– ident: R26
  doi: 10.1055/s-2007-1002181
– ident: R16
  doi: 10.1152/jappl.1974.37.2.247
– ident: R59
  doi: 10.1006/gyno.2001.6153
– ident: R28
– ident: R36
  doi: 10.1016/S0009-9236(96)90172-1
– ident: R34
  doi: 10.1016/0009-8981(90)90175-R
– ident: R48
  doi: 10.1111/j.1469-7793.2001.00633.x
– ident: R17
  doi: 10.1016/S0015-0282(00)01553-3
– ident: R2
  doi: 10.1006/cyto.1996.0178
– ident: R18
  doi: 10.1152/ajpendo.00134.2003
– ident: R32
  doi: 10.2165/00007256-198806060-00002
– ident: R33
  doi: 10.1080/07315724.2004.10719376
– ident: R9
  doi: 10.1080/026404102753576116
– ident: R19
  doi: 10.1530/eje.0.1430031
– ident: R3
– ident: R44
  doi: 10.1152/physrev.2000.80.3.1055
– ident: R51
  doi: 10.1152/jappl.2000.89.6.2325
– ident: R37
  doi: 10.1055/s-2007-972899
– ident: R5
  doi: 10.1016/0024-3205(93)90002-K
– ident: R4
  doi: 10.1249/00005768-199204000-00007
– ident: R27
  doi: 10.1006/brbi.1999.0570
– ident: R23
  doi: 10.1016/S0015-0282(99)00325-8
– ident: R41
– ident: R20
  doi: 10.1111/j.1749-6632.1998.tb08334.x
– ident: R43
  doi: 10.1016/S0002-9378(99)70332-7
– ident: R38
  doi: 10.1007/BF00377443
– ident: R7
  doi: 10.1152/jappl.1991.70.5.1917
– ident: R10
  doi: 10.1016/S8756-3282(99)00243-4
– ident: R29
  doi: 10.4049/jimmunol.153.1.300
– ident: R53
  doi: 10.1139/h00-022
– ident: R46
  doi: 10.1210/jc.86.6.2403
SSID ssj0014451
Score 2.1840692
Snippet 1 Children's Exercise and Nutrition Centre and 2 Departments of Pediatrics and Medicine, McMaster University, Hamilton, Ontario, Canada Submitted 10 February...
This study determined the influence of gender, menstrual phase (MP), and oral contraceptive (OC) use on immunological changes in response to endurance...
SourceID proquest
crossref
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 979
SubjectTerms Adult
Bicycling
Bicycling - physiology
Biological and medical sciences
Birth control
Changes
Contraceptives, Oral - administration & dosage
Exercise Test
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Gender
Gynecology. Andrology. Obstetrics
Hormonal contraception
Humans
Immunobiology
Immunology
Influence
Male
Medical sciences
Menstrual Cycle - drug effects
Menstrual Cycle - immunology
Menstruation
Modulation of the immune response (stimulation, suppression)
Physical Endurance - drug effects
Physical Endurance - immunology
Sex Factors
Title Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling
URI http://jap.physiology.org/cgi/content/abstract/99/3/979
https://www.ncbi.nlm.nih.gov/pubmed/15879167
https://www.proquest.com/docview/222204537/abstract/
https://search.proquest.com/docview/17412536
https://search.proquest.com/docview/68481328
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5FRUJcELQ8TKHsAXFJXbJeP48VtBRUysURua3W9rqtROyKOJHSf8s_YWZ3_YhoEHCxovi13vk8OzOemY-QNxkHn6H0lZvlMnB9cK_drAwY-DyMKV-yssh1lu9FeDb1P8-C2Wj0c5C1tGyyo_z2zrqS_5Eq_AdyxSrZf5Bsd1H4A36DfGELEobtX8n4U8swgibfpSaFwymbK90WFmusrqQhTtR1-DotXeo8lpUaLzGKX42vsUCk04CmDnhhqlx09qym1gA1-72GHcU4X2Mt5eUWm1Zam1bHS0x3J2wElcTBIOIA8IAZWhhkoX751qvBuSzUlakhulVV_83qg1qhTz9I9Jd9fDeVPyrkerBxYCw_siHaNpwRdPlazaCCAPV_O1D99DaFtVeO4GZNXPB1zGKtrPIGx5qF9mpWuxv6JYtiPlDViSGx-X0JCTxNXQATZifrSDcV0vG3ftVsMwUuvorT6fm5SE9m6eZebSTEcRhzHmH1-T0vSgKMD3ycdVlIDPvDmRC0eRybggiDeLdlCJsGVNvUGnN65QKmqjR8LNsdJm04pY_IQ4sOemzg-5iMVLVL9o4r2dTzNX1LOxGsd8n9LzbVY4-sOnDTuqQG3Ie0gzbV0D6kCGy6AWwKwKZ1RTeATS2w6XVFW2DTpqYdsKkF9hMyPT1J35-5liTEzYNk0rheWLAEuwgy6RdMlmHAFUAgxz6IsOCAIQBrfpFw6ZWRlCoPOU8yMNGypFDlJMr5U7JT1ZV6TigrOFNZkWUynvihChKZsFLzGWRKRpI5ZNLOvLgxvWCE9qEDTwyFJbSwkOA1cMhhKyHRv3oCw0spAAVPSxLBBYBR3BSlQ-hdh8NRoj3MIQcbgu5HEmHHcQ633G8lL6yuWgjwApB3gkcOed3thYUEvw7KStXLBZzvg7PDw-1HhEi9wb3YIc8MoPp7A3LBz4xe_PHe--RB_8a_JDsAF_UKTPomO9AvxS8aTwAQ
link.rule.ids 315,786,790,27957,27958
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+gender%2C+menstrual+phase%2C+oral+contraceptive+use+on+immunological+changes+in+response+to+prolonged+cycling&rft.jtitle=Journal+of+applied+physiology+%281985%29&rft.au=Timmons%2C+Brian+W&rft.au=Hamadeh%2C+Mazen+J&rft.au=Devries%2C+Michaela+C&rft.au=Tarnopolsky%2C+Mark+A&rft.date=2005-09-01&rft.pub=American+Physiological+Society&rft.issn=8750-7587&rft.eissn=1522-1601&rft.volume=99&rft.issue=3&rft.spage=979&rft_id=info:doi/10.1152%2Fjapplphysiol.00171.2005&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=886833711
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8750-7587&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8750-7587&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8750-7587&client=summon